Incorporating the Study Participant&#39;s Voice into Early Development of ACU193 for Early Alzheimer&#39;s Disease: A Qualitative Interview Study Following Participation in the INTERCEPT-AD Study

ACU193 - Acumen Pharma

Kelly Johnston 1; Victoria Brown 1; Carrie Presnall 1; Elizabeth Merikle 1; Stephanie Cline 2; Todd Feaster 2

Oct 23, 2023